biote Corp (NASDAQ:BTMD) — Stock Price
biote Corp (NASDAQ:BTMD) is currently trading at $1.54 USD, up 4.05% today. Over the past 52 weeks, shares have ranged between $1.30 and $3.49. This page tracks biote Corp's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see biote Corp stock valuation.
biote Corp (BTMD) Stock Price Chart — Daily History & Trading Volume
The chart below tracks biote Corp's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
biote Corp Income Statement — Revenue, Profit & Earnings by Year
biote Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $192.22 Million | $197.19 Million | $185.36 Million | $164.96 Million | $139.40 Million |
| Cost of Revenue | $54.86 Million | $58.13 Million | $57.88 Million | $54.58 Million | $48.82 Million |
| Gross Profit | $137.36 Million | $139.06 Million | $127.48 Million | $110.38 Million | $90.58 Million |
| Research & Development | — | — | — | — | — |
| SG&A | $101.81 Million | $107.45 Million | $93.42 Million | $165.50 Million | $49.05 Million |
| Total Operating Expenses | $101.81 Million | $107.45 Million | $98.83 Million | $171.10 Million | $56.02 Million |
| Operating Income | $35.55 Million | $31.61 Million | $28.66 Million | $-60.72 Million | $34.56 Million |
| EBITDA | $39.22 Million | $15.59 Million | $39.54 Million | $7.96 Million | $35.98 Million |
| EBIT | $35.55 Million | $12.02 Million | $38.74 Million | $5.76 Million | $34.58 Million |
| Interest Expense | $10.96 Million | $11.00 Million | $6.36 Million | $4.05 Million | $1.67 Million |
| Income Before Tax | $37.58 Million | $1.02 Million | $-123.00K | $1.71 Million | $32.91 Million |
| Income Tax Expense | $5.99 Million | $970.00K | $2.68 Million | $388.00K | $286.00K |
| Net Income | $27.05 Million | $3.16 Million | $3.32 Million | $-969.00K | $32.62 Million |
biote Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes biote Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $107.61 Million | $122.37 Million | $155.29 Million | $111.64 Million | $54.33 Million |
| Total Current Assets | $54.67 Million | $68.13 Million | $122.34 Million | $101.18 Million | $47.09 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $6.87 Million | $7.70 Million | $8.17 Million | $6.95 Million | $5.23 Million |
| Inventory | $19.06 Million | $14.85 Million | $17.31 Million | $11.18 Million | $9.62 Million |
| Property, Plant & Equipment | — | — | — | $3.56 Million | $2.69 Million |
| Goodwill | $5.83 Million | $5.83 Million | $0.00 | — | — |
| Total Liabilities | $158.01 Million | $224.57 Million | $191.84 Million | $169.92 Million | $50.20 Million |
| Total Current Liabilities | $44.99 Million | $51.51 Million | $22.21 Million | $18.77 Million | $17.31 Million |
| Long-term Debt | $100.78 Million | $101.20 Million | $106.63 Million | $112.09 Million | $31.96 Million |
| Net Debt | $85.80 Million | $71.52 Million | $25.87 Million | $41.20 Million | $10.57 Million |
| Total Stockholder Equity | $-58.54 Million | $-105.93 Million | $-29.40 Million | $-44.46 Million | $4.12 Million |
| Retained Earnings | $-49.55 Million | $-100.30 Million | $-29.39 Million | $-44.46 Million | $4.17 Million |
biote Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how biote Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $35.19 Million | $45.24 Million | $26.88 Million | $-9.16 Million | $33.72 Million |
| Capital Expenditures | $5.01 Million | $6.43 Million | $2.71 Million | $1.84 Million | $3.81 Million |
| Free Cash Flow | $30.18 Million | $38.81 Million | $24.17 Million | $-10.99 Million | $29.91 Million |
| Investing Cash Flow | $-6.86 Million | $-18.80 Million | $-2.71 Million | $-1.84 Million | $-3.81 Million |
| Financing Cash Flow | $-43.55 Million | $-76.08 Million | $-14.38 Million | $63.46 Million | $-20.34 Million |
| Dividends Paid | $1.73 Million | $4.74 Million | $8.69 Million | $12.89 Million | $11.40 Million |
| Stock-Based Compensation | $8.92 Million | $8.73 Million | $9.06 Million | $82.18 Million | $0.00 |
| Depreciation | $3.67 Million | $3.57 Million | $2.99 Million | $2.20 Million | $1.40 Million |
| Change in Cash | $-15.22 Million | $-49.66 Million | $9.77 Million | $52.47 Million | $9.56 Million |
biote Corp Earnings History — EPS Actual vs. Analyst Estimates
Track biote Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 12, 2026 | 0.08 | 0.10 | -19.03% |
| Mar 18, 2026 | 0.07 | 0.09 | -19.77% |
| Nov 05, 2025 | 0.22 | 0.13 | +69.23% |
| Aug 08, 2025 | 0.10 | 0.08 | +25.00% |
| May 09, 2025 | 0.37 | 0.14 | +164.29% |
| Mar 12, 2025 | 0.10 | 0.11 | -9.09% |
| Nov 12, 2024 | 0.33 | 0.12 | +175.00% |
| Aug 08, 2024 | -0.15 | 0.09 | -266.67% |